Search
Glecaprevir
go.drugbank.com/drugs/DB13879ApprovedInvestigationalthree years and older. … The ultimate goal of the combination treatment is to achieve sustained virologic response (SVR) and cure the patients from the infection.
Mixtures: MAVIRET FILM-COATED TABLET 100MG/40MG, MAVIRET (GLECAPREVIR 100MG/ PIBRENTASVIR 40MG) FILM COATED TABLETSCategories: glecaprevir and pibrentasvir, Amino Acids, Peptides, and ProteinsAspiration Pneumonia
go.drugbank.com/conditions/DBCOND0031880Drugs: PrednisoloneSynonyms: Pneumonitis due to inhalation of food and vomitDesogestrel
go.drugbank.com/drugs/DB00304ApprovedInvestigationalDesogestrel, a prodrug, is a third generation progestogen[A176315] and hence, a member of the gonane family which was largely used in Europe before being approved in the US and Canada. … [T521] Desogestrel is now produced semi-synthetically from naturally occurred plant steroids.[F4127] In the US, desogestrel is found only in combination with [ethinyl estradiol].
Mixtures: Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol, Desogestrel and Ethinyl Estradiol and Ethinyl EstradiolCategories: desogestrel and estrogen, desogestrel and ethinylestradiolFormestane
go.drugbank.com/drugs/DB08905ApprovedWithdrawnIt is not US FDA approved, and the intramuscular injection form of formestane (Lentaron) which was approved in Europe has been withdrawn. … Some clinical data has suggested that the clinically recommended dose of 250mg was too low.
Categories: Antineoplastic and Immunomodulating Agents, Hormone Antagonists and Related AgentsBlisters
go.drugbank.com/conditions/DBCOND0057795Synonyms: Blister of skin AND/OR mucosa, Blister of skin AND/OR mucosa (disorder)Nirsevimab
go.drugbank.com/drugs/DB16258ApprovedInvestigational[L44146] Nirsevimab was also approved by Health Canada on April 19, 2023 and by the FDA in July 17, 2023 for the same indication.[L46392,L47461] … [A254571,L44146] On November 2022, nirsevimab was approved by the EMA for the prevention of RSV lower respiratory tract disease in newborns and infants.
Categories: Amino Acids, Peptides, and Proteins, Immune Sera and ImmunoglobulinsMedrogestone
go.drugbank.com/drugs/DB09124ApprovedWithdrawnIt was conceived as an alternative for an orally effective contraceptive option.[A31526] It was developed by Ayerst, approved in Canada in 1969 and its current status is cancelled post-marketing. … Medrogestone (INN), also known as 6,17α-dimethyl-6-dehydroprogesterone, is a progestational agent derived from 17-methylprogesterone.
Mixtures: PRESOMEN CONTI 0.6MG/2MG, PRESOMEN CONTI 0.6MG/2MGCategories: medrogestone and estrogen, Genito Urinary System and Sex HormonesDeep vein thrombophlebitis
go.drugbank.com/conditions/DBCOND0095181Drugs: EnoxaparinSynonyms: Venous phlebitis and thrombophlebitis deep, Acute embolism and thrombosis of unspecified deep veins of lower extremityTeplizumab
go.drugbank.com/drugs/DB06606ApprovedInvestigational[L44096] In April 2026, the FDA approved an expanded indication for teplizumab, lowering the eligible age range from 8 years and older down to 1 year and older for patients with Stage 2 T1D.[L56140] … Teplizumab was designed as an Fc-non-binding antibody in order to reduce the incidence of CRS.
Categories: Alimentary Tract and Metabolism, Amino Acids, Peptides, and ProteinsCilgavimab
go.drugbank.com/drugs/DB16393ApprovedInvestigational[A243356, A243361] Cilgavimab (formerly AZD1061) is a recombinant monoclonal antibody produced in Chinese hamster ovary (CHO) cells derived from a neutralizing antibody isolated from a patient with a natural … [A243351, A243361, L39411] Cilgavimab is not approved for any indication by the FDA.
Categories: tixagevimab and cilgavimab, Amino Acids, Peptides, and Proteins